The global blood coagulants market is booming, projected to reach \$670 million by 2033 with a CAGR of 6.2%. Discover key trends, drivers, and restraints impacting this rapidly growing sector, including the rise of recombinant factors and increasing prevalence of bleeding disorders. Learn more about leading players like Pfizer, Bayer, and Novo Nordisk.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.